610 Medizin und Gesundheit
Refine
Year of publication
- 2021 (1202)
- 2020 (867)
- 2022 (682)
- 2019 (658)
- 2018 (588)
- 2017 (449)
- 2016 (402)
- 2013 (348)
- 2010 (341)
- 2014 (315)
- 2023 (315)
- 2012 (314)
- 2015 (314)
- 2009 (299)
- 2011 (249)
- 2008 (240)
- 2007 (215)
- 2006 (201)
- 2004 (172)
- 2005 (153)
- 2003 (125)
- 2002 (113)
- 2024 (100)
- 2001 (76)
- 1998 (37)
- 2000 (34)
- 1999 (30)
- 1991 (25)
- 1913 (24)
- 1993 (24)
- 1994 (19)
- 1997 (14)
- 1996 (11)
- 1988 (10)
- 1995 (10)
- 1990 (9)
- 1992 (9)
- 1908 (8)
- 1885 (7)
- 1896 (6)
- 1898 (6)
- 1907 (6)
- 1914 (6)
- 1916 (6)
- 1927 (6)
- 1983 (6)
- 1989 (6)
- 1897 (5)
- 1920 (5)
- 1984 (5)
- 1880 (4)
- 1881 (4)
- 1901 (4)
- 1919 (4)
- 1921 (4)
- 1922 (4)
- 1925 (4)
- 1926 (4)
- 1938 (4)
- 1947 (4)
- 1949 (4)
- 1960 (4)
- 1966 (4)
- 1985 (4)
- 1986 (4)
- 1855 (3)
- 1858 (3)
- 1859 (3)
- 1867 (3)
- 1869 (3)
- 1876 (3)
- 1887 (3)
- 1890 (3)
- 1894 (3)
- 1899 (3)
- 1900 (3)
- 1909 (3)
- 1911 (3)
- 1917 (3)
- 1923 (3)
- 1924 (3)
- 1928 (3)
- 1933 (3)
- 1937 (3)
- 1953 (3)
- 1959 (3)
- 1964 (3)
- 1965 (3)
- 1981 (3)
- 1722 (2)
- 1743 (2)
- 1749 (2)
- 1750 (2)
- 1801 (2)
- 1825 (2)
- 1830 (2)
- 1831 (2)
- 1843 (2)
- 1845 (2)
- 1852 (2)
- 1857 (2)
- 1861 (2)
- 1863 (2)
- 1864 (2)
- 1865 (2)
- 1874 (2)
- 1883 (2)
- 1889 (2)
- 1892 (2)
- 1893 (2)
- 1902 (2)
- 1904 (2)
- 1905 (2)
- 1906 (2)
- 1910 (2)
- 1912 (2)
- 1929 (2)
- 1930 (2)
- 1931 (2)
- 1932 (2)
- 1935 (2)
- 1936 (2)
- 1951 (2)
- 1961 (2)
- 1962 (2)
- 1963 (2)
- 1968 (2)
- 1974 (2)
- 1978 (2)
- 1987 (2)
- 1488 (1)
- 1554 (1)
- 1643 (1)
- 1674 (1)
- 1675 (1)
- 1678 (1)
- 1690 (1)
- 1703 (1)
- 1719 (1)
- 1721 (1)
- 1735 (1)
- 1748 (1)
- 1751 (1)
- 1752 (1)
- 1753 (1)
- 1760 (1)
- 1778 (1)
- 1779 (1)
- 1791 (1)
- 1797 (1)
- 1805 (1)
- 1806 (1)
- 1808 (1)
- 1812 (1)
- 1820 (1)
- 1822 (1)
- 1826 (1)
- 1828 (1)
- 1832 (1)
- 1834 (1)
- 1838 (1)
- 1839 (1)
- 1842 (1)
- 1846 (1)
- 1847 (1)
- 1849 (1)
- 1850 (1)
- 1854 (1)
- 1856 (1)
- 1860 (1)
- 1870 (1)
- 1872 (1)
- 1875 (1)
- 1878 (1)
- 1879 (1)
- 1895 (1)
- 1903 (1)
- 1915 (1)
- 1918 (1)
- 1939 (1)
- 1940 (1)
- 1941 (1)
- 1942 (1)
- 1946 (1)
- 1954 (1)
- 1958 (1)
- 1969 (1)
- 1971 (1)
- 1976 (1)
- 1977 (1)
- 1979 (1)
- 1980 (1)
- 1982 (1)
Document Type
- Article (6128)
- Doctoral Thesis (1995)
- Preprint (283)
- Part of Periodical (245)
- Conference Proceeding (207)
- Book (175)
- Contribution to a Periodical (172)
- Review (58)
- Part of a Book (39)
- Working Paper (17)
Language
- English (6243)
- German (3039)
- Latin (26)
- mis (13)
- Multiple languages (13)
- French (11)
- Portuguese (1)
- Romanian (1)
- Russian (1)
- Spanish (1)
Has Fulltext
- yes (9350) (remove)
Keywords
- inflammation (98)
- COVID-19 (71)
- SARS-CoV-2 (55)
- apoptosis (42)
- cancer (41)
- Inflammation (40)
- glioblastoma (38)
- breast cancer (34)
- autophagy (32)
- Cancer (30)
Institute
- Medizin (7495)
- Pharmazie (297)
- Biowissenschaften (271)
- Präsidium (255)
- Biochemie, Chemie und Pharmazie (238)
- Biochemie und Chemie (216)
- Frankfurt Institute for Advanced Studies (FIAS) (155)
- Georg-Speyer-Haus (130)
- Sportwissenschaften (130)
- Psychologie (94)
Die Krebsstammzellforschung gelangte in den letzten Jahren vermehrt in den Fokus der Tumorforschung. Im Tumor bilden Krebsstammzellen eine kleine Population an Zellen mit Stammzelleigenschaften, wodurch sie eine große Rolle bei der Entstehung von Rezidiven, Metastasen, sowie der Entwicklung von Chemotherapieresistenzen spielen. Um eine gezielte Bekämpfung von Krebsstammzellen zu ermöglichen, müssen diese im
Tumor zunächst zuverlässig durch Krebsstammzellmarker detektiert werden können.
Gerade bei soliden pädiatrischen Tumoren, wie dem Hepatoblastom, ergeben sich hierbei Schwierigkeiten dadurch, dass im sehr heterogenen Tumorgewebe viele Zellen aufgrund der embryonalen Natur des Tumors bereits Stammzellmarker exprimieren, ohne dass es sich bei diesen Zellen um Krebsstammzellen handelt. Das Hepatoblastom ist mit 2/3 der Lebertumore des Kindes die häufigste maligne Leberneoplasie im Kindesalter.
Auch wenn es bereits Hinweise auf das Vorliegen von Krebsstammzellen im Hepatoblastom gibt, so konnten diese bisher nicht genauer durch fest definierte Krebsstammzellmarker identifiziert werden.
Um dies zu erreichen, wurden in dieser Arbeit die beiden Hepatoblastomzelllinien HuH6 und HepG2 auf die Expression der bereits bekannten Krebsstammzellmarker CD90, CD34 und CXCR4 überprüft. Zusätzlich wurde auf eine Bindung des „oval cell“ Antikörpers, OV-6, untersucht. Mittels Durchflusszytometrie-Analysen konnte eine Zellpopulation gefunden werden, welche die Oberflächenmarker CD34 und CD90 koexprimiert und gleichzeitig den OV-6 Antikörper bindet. Im nächsten Schritt wurden die Zellen auf einige Krebsstammzelleigenschaften überprüft. Zur weiteren Untersuchung dieser Subpopulation erfolgte mittels MACS (magnetic activated cell sorting) eine Anreicherung der CD90 exprimierenden Zellen. Diese wurde mittels qPCR auf die Expression der Pluripotenzmarker Oct4 und Nanog, sowie der Zytidindeaminase AID untersucht. Es konnte eine signifikant erhöhte Expression von AID und Oct4 detektiert werden. Im Gegensatz hierzu zeigte sich die Expression von EpCAM, c-myc und Albumin, welche als Kontrollgene untersucht wurden, nicht signifikant erhöht. Um auf das Metastasierungspotential der CD90 angereicherten Zellen rückzuschließen, wurde ein Migrationsassay mit angereicherten und depletierten Zellen durchgeführt. Hier wiesen die CD90 angereicherten Zellen, im Vergleich zu den depletierten Zellen eine erhöhte Migration auf. Im Tumorsphäroid-Assay war die HepG2 Zelllinie in der Lage Tumor-61 -sphäroide auszubilden. Nach der Passagierung zeigten diese eine erhöhte Expression der Krebsstammzellmarker CD90 und CD34, sowie der Pluripotenzmarker Oct4 und Nanog.
Zusammengefasst kann mit den Krebsstammzellmarkern CD90, CD34 und OV-6 eine Subpopulation im Hepatoblastom identifiziert werden, die nach unseren Analysen Krebsstammzelleigenschaften aufweisen. Mithilfe dieses Markersets können nun neue Therapieansätze auf ihre Effektivität, Krebsstammzellen gezielt zu eliminieren, getestet werden.
Gene therapy has garnered increasing interest over recent decades. Several therapies employing gene transfer mechanisms have been developed, and, of these, adeno-associated virus (AAV) vectors have demonstrated viability for use with in vivo gene therapy. Several AAV-based therapeutics have received regulatory approval in the last few years including those for retinal disease, spinal muscular atrophy or aromatic L-amino acid decarboxylase deficiency. Lately, with the introduction of novel liver-directed AAV vector-based therapeutics for the treatment of haemophilia A and B, gene therapy has attracted significant attention in the hepatology community, with the liver increasingly recognised as a target for gene therapy. However, the introduction of foreign DNA into hepatocytes is associated with a risk of hepatic reactions, with raised ALT (alanine aminotransferase) and AST (aspartate aminotransferase) being – so far – the most commonly reported side effects. The complete mechanisms underlying the ALT flairs remain to be determined and the long-term risks associated with these new treatments is not yet known. The liver community is increasingly being asked to support liver-directed gene therapy to mitigate potential liver associated harm. In this review, we focus on AAV vector-based gene therapy, shedding light on this promising technique and its remarkable success in haemophilia, with a special focus on hepatic complications and their management in daily clinical practice.
Branching allows neurons to make synaptic contacts with large numbers of other neurons, facilitating the high connectivity of nervous systems. Neuronal arbors have geometric properties such as branch lengths and diameters that are optimal in that they maximize signaling speeds while minimizing construction costs. In this work, we asked whether neuronal arbors have topological properties that may also optimize their growth or function. We discovered that for a wide range of invertebrate and vertebrate neurons the distributions of their subtree sizes follow power laws, implying that they are scale invariant. The power-law exponent distinguishes different neuronal cell types. Postsynaptic spines and branchlets perturb scale invariance. Through simulations, we show that the subtree-size distribution depends on the symmetry of the branching rules governing arbor growth and that optimal morphologies are scale invariant. Thus, the subtree-size distribution is a topological property that recapitulates the functional morphology of dendrites.
Traditionally, biosensors are designed to detect one specific analyte. Nevertheless, disease progression is regulated in a highly interactive way by different classes of biomolecules like proteins and nucleic acids. Therefore, a more comprehensive analysis of biomarkers from a single sample is of utmost importance to further improve both, the accuracy of diagnosis as well as the therapeutic success. This review summarizes fundamentals like biorecognition and sensing strategies for the simultaneous detection of proteins and nucleic acids and discusses challenges related to multianalyte biosensor development. We present an overview of the current state of biosensors for the combined detection of protein and nucleic acid biomarkers associated with widespread diseases, among them cancer and infectious diseases. Furthermore, we outline the multianalyte analysis in the rapidly evolving field of single-cell multiomics, to stress its significance for the future discovery and validation of biomarkers. Finally, we provide a critical perspective on the performance and translation potential of multianalyte biosensors for medical diagnostics.
An 80-year-old post–coronary artery bypass graft (CABG) patient had an acute coronary syndrome with non–ST-segment elevation myocardial infarction (ACS-NSTE) with saphenous vein graft (SVG)–obtuse marginal stenosis. High-definition intravascular ultrasound revealed an underexpanded SVG stent with a hyperechoic structure. Optical coherence tomography confirmed surgical clip causing compression, resolved by post-dilation. This case underscores ACS-NSTE complexity post-CABG and the critical role of coronary imaging in optimizing interventions by addressing surgical clip–induced compression.
Highlights
• Hyperglycaemia, in rodents, is consistently associated with cognitive impairments.
• The strength of this association is supported by the heterogeneity of the studies.
• The study of the role of insulin on cognition is mainly limited to spatial memory.
• Preclinical studies on the role of insulin signalling on cognition are male biased.
Abstract
Beside its involvement in somatic dysfunctions, altered insulin signalling constitutes a risk factor for the development of mental disorders like Alzheimer’s disease and obsessive-compulsive disorder. While insulin-related somatic and mental disorders are often comorbid, the fundamental mechanisms underlying this association are still elusive. Studies conducted in rodent models appear well suited to help decipher these mechanisms. Specifically, these models are apt to prospective studies in which causative mechanisms can be manipulated via multiple tools (e.g., genetically engineered models and environmental interventions), and experimentally dissociated to control for potential confounding factors. Here, we provide a narrative synthesis of preclinical studies investigating the association between hyperglycaemia – as a proxy of insulin-related metabolic dysfunctions – and impairments in working and spatial memory, and attention. Ultimately, this review will advance our knowledge on the role of glucose metabolism in the comorbidity between somatic and mental illnesses.
Highlights
• Increased values in SVD, suggesting reduced oxygen extraction fraction (OEF).
• Vascular dysfunction and microstructural impairment limit OEF capacity.
• Association between prolonged and more alkaline intracellular pH.
• Adaptation of intracellular energy metabolism compensates for reduced OEF.
Abstract
Background: We aimed to investigate whether combined phosphorous (31P) magnetic resonance spectroscopic imaging (MRSI) and quantitative T′2 mapping are able to detect alterations of the cerebral oxygen extraction fraction (OEF) and intracellular pH (pHi) as markers the of cellular energy metabolism in cerebral small vessel disease (SVD).
Materials and methods: 32 patients with SVD and 17 age-matched healthy control subjects were examined with 3-dimensional 31P MRSI and oxygenation-sensitive quantitative T′2 mapping (1/T′2 = 1/T2* - 1/T2) at 3 Tesla (T). PHi was measured within the white matter hyperintensities (WMH) in SVD patients. Quantitative T′2 values were averaged across the entire white matter (WM). Furthermore, T′2 values were extracted from normal-appearing WM (NAWM) and the WMH and compared between patients and controls.
Results: Quantitative T′2 values were significantly increased across the entire WM and in the NAWM in patients compared to control subjects (149.51 ± 16.94 vs. 138.19 ± 12.66 ms and 147.45 ± 18.14 vs. 137.99 ± 12.19 ms, p < 0.05). WM T′2 values correlated significantly with the WMH load (ρ=0.441, p = 0.006). Increased T′2 was significantly associated with more alkaline pHi (ρ=0.299, p < 0.05). Both T′2 and pHi were significantly positively correlated with vascular pulsatility in the distal carotid arteries (ρ=0.596, p = 0.001 and ρ=0.452, p = 0.016).
Conclusions: This exploratory study found evidence of impaired cerebral OEF in SVD, which is associated with intracellular alkalosis as an adaptive mechanism. The employed techniques provide new insights into the pathophysiology of SVD with regard to disease-related consequences on the cellular metabolic state.
The question of whether nuclear energy—as a source with relatively low carbon dioxide emissions—can be classified as a sustainable energy source has come into focus in connection with climate change. There is a controversy over securing independence from fossil fuels and gas supplies from other countries through a revival of nuclear energy. On the other hand, some viewpoints are critical: the handling of nuclear waste and the still unclear risks to human health and the environment, especially in light of recent perils from Russian military attacks on Ukrainian nuclear plants. To evaluate the worldwide publications on nuclear energy under health and environmental aspects, socio-economic parameters were included to provide an informed background for all stakeholders, from scientists to decision-makers. The correlation between the number of nuclear power plants and the publication output of the countries is proven to be highly significant. Thus, the operating countries publish the most. It has been shown that the development and economic use of nuclear energy are major stimuli for scientific endeavors. Reactor accidents have also spurred research. Mathematical risk modeling has been the area with the highest citation rate to date, but environmental and health aspects have become more important, especially after major accidents. The results show the importance of economic interests in research on nuclear energy from health and environmental aspects. Against the background of transnational hazards, global research participation should be encouraged. Moreover, the international debate should not ignore the reality of threats and their possible impacts.
Despite antagonizing attempts from the tobacco industry, passive inhalation of tobacco smoke is known to be cancerogenic and toxic to human health for decades. Nonetheless, millions of non-smoking adults and children are still victims of second-hand smoke. Accumulation of particulate matter (PM) in confined spaces such as the car are particularly harmful due to high concentrations. We here aimed to analyze the specific effects of ventilation conditions in the setting of a car. By the use of the measuring platform TAPaC (tobacco-associated particulate matter emissions inside a car cabin), 3R4F reference cigarettes, Marlboro red, and Marlboro gold were smoked in a car interior with a volume of 3.709 m3. Seven different ventilation conditions (C1–C7) were analyzed. Under C1, all windows were closed. Under C2–C7, the car ventilation was turned on power level 2/4 with the air directed towards the windshield. Only the passenger side window was opened, where an outer placed fan could create an airstream speed of 15.9–17.4 km/h at one meter distance to simulate a driving car. C2: Window 10 cm opened. C3: Window 10 cm opened with the fan turned on. C4: Window half-opened. C5: Window half-opened with the fan turned on. C6: Window fully opened. C7: Window fully opened with the fan turned on. Cigarettes were remotely smoked by an automatic environmental tobacco smoke emitter and a cigarette smoking device. Depending on the ventilation condition the cigarettes emitted different mean PM concentrations after 10 min under condition C1 (PM10: 1272–1697 µg/m3, PM2.5: 1253–1659 µg/m3, PM1: 964–1263 µg/m3) under C2, C4, and C6 (PM10: 68.7–196.2 µg/m3, PM2.5: 68.2–194.7 µg/m3, PM1: 66.1–183.8 µg/m3) C3, C5, and C7 (PM10: 73.7–139 µg/m3, PM2.5: 72–137.9 µg/m3, PM1:68.9–131.9 µg/m3). Vehicle ventilation is insufficient to protect passengers from toxic second-hand smoke completely. Brand-specific variations of tobacco ingredients and mixtures markedly influence PM emissions under ventilation conditions. The most efficient ventilation mode to reduce PM exposure was achieved by opening the passenger´s window 10 cm and turning the onboard ventilation on power level 2/4. In-vehicle smoking should be banned to preserve innocent risk groups (e.g., children) from harm.
The combination of pamapimod and pioglitazone (KIN001) has a synergetic antiviral, anti-inflammatory, and antifibrotic activity, which may prevent evolution toward COVID-19-associated severe respiratory failure. In a randomized, placebo-controlled, double-blind, phase 2, multicenter trial, 128 non-critically ill hospitalized patients with confirmed COVID-19 were treated with KIN001 or a placebo for 28 days. The proportion of patients alive and free of oxygen or respiratory support at the end of the therapy was lower than anticipated but not different in the two groups (KIN001 n = 19, 29%, placebo n = 21, 33%). 85 participants had at least one adverse event, with no difference in the number and distribution of events between the two groups. The clinical trial was stopped for futility, mainly due to a lower-than-expected incidence of the primary endpoint. KIN001 was safe and well-tolerated but had no significant effect on clinical outcome.